(PharmaNewsWire.Com, May 28, 2021 ) The report "Microfluidic Components Market by Product (Valve, Solenoid Valve, Check Valve, Nozzle, Tubing, Micropump, Microneedle, Shuttle Valve), Industry (Automotive, Aerospace & Defense, Healthcare, Consumer Electronics, Oil & Gas) - Global Forecast to 2024", is expected to reach USD 6.1 billion by 2024 from an estimated USD 3.3 billion in 2019, at a CAGR of 12.7%.
The Growth in Microfluidic Components Market is driven by rising demand for point-of-care testing, technological advancements, increasing focus on data precision and accuracy, fast return on investments, growing demand for miniature portable devices, and growing demand for consumer electronics and wearable devices. Factors such as emergence of microfluidics-based 3D cell culture, increasing demand for regenerative medicine, increasing application areas of the microfluidics technology are expected to offer significant growth opportunities for market players. However, standardization and commercialization of components is one of the major market challenges.
Solenoid valves segment is expected to grow at a higher CAGR;
Based on valve type, the microfluidic components market is segmented into solenoid valves, flow control valves, check valves, shuttle valves, pressure relief valves, proportional valves, and other valves. Solenoid valves are expected to grow at the highest CAGR during the forecast period due to factors like increased application scope in the automotive industry, the shift towards renewable sources for power generation, growing investments in various industries, and increasing government regulations on end-use industries across developing economies.
The healthcare segment is expected to account for the largest share of the microfluidic components market in 2019;
The healthcare industry segment accounted for the largest share of the market in 2019. The large share of this segment can be attributed to factors such as, high healthcare spending, growing demand for process automation, rising government funding in the healthcare sector, growing demand for point-of-care testing, and demand for enhanced safety.
The Asia Pacific region is expected to grow at the highest rate in the market;
The microfluidic components market in the Asia Pacific is estimated to grow at the highest CAGR during the forecast period. Increasing industrialization, investments in water infrastructure, growth in various industries (such as chemicals, power & energy, and aerospace), increasing number of infrastructural development projects (especially in China and India), rising standard of living, and growing urbanization are factors driving the adoption of microfluidic components in the Asia Pacific.
Key Market Players;
The prominent players in the global microfluidic components market are Parker Hannifin Corporation (US), IDEX Corporation (US), Fluigent SA (France), Staiger GmbH & Co. KG (Germany), SMC Corporation (Japan), Camozzi Automation Spa Società Unipersonale (Italy), Aignep s.p.a. (Italy), FIM Valvole Srl (Italy), Humphrey Products Corporation (US), The Lee Company (US), Dolomite Microfluidics (UK), Cellix Ltd. (Ireland), Elveflow (France), and Christian Bürkert GmbH & Co. KG (Germany).
Recent developments;
- In December 2017, Parker launched VSO LowPro GC, a microfluidic valve.
- In 2018 Parker Aerospace, a business segment of Parker Hannifin Corporation, opened its second global Customer Response Center (CRC) in Singapore, with the aim to provide more local insights and potentially faster resolution of issues.
- In December 2017, IDEX Health and Science acquired thinXXS, a manufacturer of disposable microfluidic components for the point of care, veterinary and life science markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
